AMDL, Inc.'s President & CEO Mr. Gary Dreher Retires
Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, andJilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc.(JPI), is a vertically integrated bio-pharmaceutical company devoted to theresearch, development, manufacturing, and marketing of diagnostic,pharmaceutical, nutritional supplement, and cosmetic products. The companyemploys approximately 320 people in the U.S. and China. The Company has anadditional 4 pharmaceutical and diagnostic products under review by variousregulatory authorities.
Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Actof 1995: The statements contained in this document include certain predictionsand projections that may be considered forward- looking statements undersecurities law. These statements involve a number of important risks anduncertainties that could cause actual results to differ materially including,but not limited to, the performance of joint venture partners, as well asother economic, competitive and technological factors involving the Company'soperations, markets, services, products, and prices. With respect to AMDLInc., except for the historical information contained herein, the mattersdiscussed in this document are forward-looking statements involving risks anduncertainties that could cause actual results to differ materially from thosein such forward-looking statements. Potential risks and uncertainties relatedto the Company's access to additional capital, competition and dependence onkey management.AMDL Contact: Kristine Szarkowitz Director-Investor Relations firstname.lastname@example.org (M) (206) 310-5323
SOURCE AMDL, Inc.
You May Also Like